FDA inspection
Saluda Medical Americas: FDA inspection ending Jan 15, 2026
FDA inspection 1299850 · No Action Indicated (NAI) · Minneapolis, MN
Key facts
| Inspection ID | 1299850 |
|---|---|
| Firm | Saluda Medical Americas |
| FEI number | 3016111136 |
| Address | 9401 James Ave S Ste 132 |
| City | Minneapolis |
| State | MN |
| ZIP | 55431 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jan 15, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data